특수 의약품 시장은 2023-20281년에 4,066억 달러, 예측 기간 중 CAGR은 13.64%로 성장할 것으로 예측됩니다.
특수 의약품 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장을 촉진하고 있는 것은 정부의 헬스케어 지출에 의한 연구개발 수요의 증가, 특수 의약품 탐색·개발 비용 삭감의 필요성, 복잡한 질환에 대한 인식을 확산히기 위한 정부 및 다양한 비영리 단체에 의한 구상 등입니다.
| 시장 범위 |
| 기준년 |
2024 |
| 종료년 |
2028 |
| 예측 기간 |
2024-2028 |
| 성장 모멘텀 |
가속 |
| 전년대비 2024년 |
11.73% |
| CAGR |
13.64% |
| 증분액 |
4,066억 달러 |
본 조사에서는 향후 수년간 특수 의약품 시장 성장을 촉진하는 주요인의 하나로 노인 인구의 증가를 들고 있습니다. 또한 제조업체에 의한 특수 의약품에 대한 연구개발 투자의 증가, 바이오의약품 산업에 대한 투자와 개발이 시장의 큰 수요로 연결됩니다.
목차
제1장 개요
제2장 시장 구도
제3장 시장 규모의 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2023
- 시장의 전망 2023-2028
제4장 시장 규모 실적
- 세계의 특수 의약품 시장 2018-2022
- 용도별 부문 분석 2018-2022
- 유통 채널별 부문 분석 2018-2022
- 지역별 부문 분석 2018-2022
- 국가별 부문 분석 2018-2022
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제6장 시장 세분화 : 용도별
- 시장 세분화
- 비교 : 용도별
- 종양 : 시장 규모와 예측 2023-2028
- 다발성 경화증 : 시장 규모와 예측 2023-2028
- 염증성 질환 : 시장 규모와 예측 2023-2028
- 감염증 : 시장 규모와 예측 2023-2028
- 기타 : 시장 규모와 예측 2023-2028
- 시장 기회 : 용도별
제7장 시장 세분화 : 유통 채널별
- 시장 세분화
- 비교 : 유통 채널별
- 오프라인 : 시장 규모와 예측 2023-2028
- 온라인 : 시장 규모와 예측 2023-2028
- 시장 기회 : 유통 채널별
제8장 고객 상황
제9장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2023-2028
- 유럽 : 시장 규모와 예측 2023-2028
- 아시아 : 시장 규모와 예측 2023-2028
- 세계의 기타 지역 : 시장 규모와 예측 2023-2028
- 미국 : 시장 규모와 예측 2023-2028
- 중국 : 시장 규모와 예측 2023-2028
- 독일 : 시장 규모와 예측 2023-2028
- 일본 : 시장 규모와 예측 2023-2028
- 영국 : 시장 규모와 예측 2023-2028
- 시장 기회 : 지역별
제10장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제11장 경쟁 구도
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- AbbVie Inc.
- Amgen Inc.
- Biodexa Pharmaceuticals PLC
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- Johnson and Johnson Services Inc.
- McKesson Corp.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- Viatris Inc.
제13장 부록
KSA
The specialty pharmaceuticals market is forecasted to grow by USD 406.6 bn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for R&D due to government healthcare expenditure, need for cost-cutting in specialty pharmaceutical discovery and development, and initiatives by government and various non-profit organizations to spread awareness of complex diseases.
Technavio's specialty pharmaceuticals market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 11.73% |
| CAGR | 13.64% |
| Incremental Value | $406.6 bn |
By Application
- Oncology
- Multiple sclerosis
- Inflammatory conditions
- Infectious diseases
- Others
By Distribution Channel
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing geriatric population as one of the prime reasons driving the specialty pharmaceuticals market growth during the next few years. Also, increase in R&D investments in specialty pharmaceuticals by manufacturers and rising investments and developments in biopharmaceutical industry will lead to sizable demand in the market.
The report on the specialty pharmaceuticals market covers the following areas:
- Specialty pharmaceuticals market sizing
- Specialty pharmaceuticals market forecast
- Specialty pharmaceuticals market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading specialty pharmaceuticals market vendors that include AbbVie Inc., Amgen Inc., Biodexa Pharmaceuticals PLC, Bristol Myers Squibb Co., CVS Health Corp., Endo International PLC, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Humana Inc., Hyphens Pharma Pte Ltd., Johnson and Johnson Services Inc., Kroger Co., McKesson Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., The Cigna Group, UnitedHealth Group Inc., and Viatris Inc.. Also, the specialty pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Specialty Pharmaceuticals Market 2018 - 2022
- Historic Market Size - Data Table on Global Specialty Pharmaceuticals Market 2018 - 2022 ($ billion)
- 4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ billion)
- 4.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
- 6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 6.3 Oncology - Market size and forecast 2023-2028
- Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
- Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
- Chart on Oncology - Year-over-year growth 2023-2028 (%)
- Data Table on Oncology - Year-over-year growth 2023-2028 (%)
- 6.4 Multiple sclerosis - Market size and forecast 2023-2028
- Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ billion)
- Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ billion)
- Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
- Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
- 6.5 Inflammatory conditions - Market size and forecast 2023-2028
- Chart on Inflammatory conditions - Market size and forecast 2023-2028 ($ billion)
- Data Table on Inflammatory conditions - Market size and forecast 2023-2028 ($ billion)
- Chart on Inflammatory conditions - Year-over-year growth 2023-2028 (%)
- Data Table on Inflammatory conditions - Year-over-year growth 2023-2028 (%)
- 6.6 Infectious diseases - Market size and forecast 2023-2028
- Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
- 6.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 6.8 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Distribution Channel
- 7.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
- 7.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 7.3 Offline - Market size and forecast 2023-2028
- Chart on Offline - Market size and forecast 2023-2028 ($ billion)
- Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
- Chart on Offline - Year-over-year growth 2023-2028 (%)
- Data Table on Offline - Year-over-year growth 2023-2028 (%)
- 7.4 Online - Market size and forecast 2023-2028
- Chart on Online - Market size and forecast 2023-2028 ($ billion)
- Data Table on Online - Market size and forecast 2023-2028 ($ billion)
- Chart on Online - Year-over-year growth 2023-2028 (%)
- Data Table on Online - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ billion)
- Data Table on Market opportunity by Distribution Channel ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.10 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- 12.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- 12.5 Biodexa Pharmaceuticals PLC
- Biodexa Pharmaceuticals PLC - Overview
- Biodexa Pharmaceuticals PLC - Product / Service
- Biodexa Pharmaceuticals PLC - Key offerings
- 12.6 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- 12.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.8 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- 12.9 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- 12.10 McKesson Corp.
- McKesson Corp. - Overview
- McKesson Corp. - Business segments
- McKesson Corp. - Key news
- McKesson Corp. - Key offerings
- McKesson Corp. - Segment focus
- 12.11 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 12.14 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- 12.15 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- 12.16 The Cigna Group
- The Cigna Group - Overview
- The Cigna Group - Product / Service
- The Cigna Group - Key offerings
- 12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 Data procurement
- 13.6 Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
